4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001012975-17-000157
Director sold 135,364 shares at an average $49.37 ($6,683,464)
- Director acquired 61,564 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| NELSEN ROBERT Director | 2017-02-21 | Sale | −1,780 | $54.17 | $96,428 | 417,265 | I: show line 1 in the form |
| NELSEN ROBERT Director | 2017-02-21 | Sale | −34,650 | $50.56 | $1,751,821 | 382,615 | I: show line 2 in the form |
| NELSEN ROBERT Director | 2017-02-22 | Sale | −46,938 | $49.90 | $2,342,408 | 335,677 | I: show line 3 in the form |
| NELSEN ROBERT Director | 2017-02-22 | Sale | −1,000 | $50.35 | $50,346 | 334,677 | I: show line 4 in the form |
| NELSEN ROBERT Director | 2017-02-23 | Sale | −42,596 | $47.73 | $2,032,979 | 292,081 | I: show line 5 in the form |
| NELSEN ROBERT Director | 2017-02-23 | Sale | −8,400 | $48.75 | $409,482 | 283,681 | I: show line 6 in the form |
| NELSEN ROBERT Director | 2016-06-30 | Other acquisition | +25,412 | 73,078 | D: show line 7 in the form | ||
| NELSEN ROBERT Director | 2016-08-08 | Other acquisition | +36,152 | 109,230 | D: show line 8 in the form | ||
| Open-market sales · 135,364 sh · avg $49.37 · $6,683,464 | |||||||
Loading xslF345X03/edgar.xml…